echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Bai osaitu has a strategic cooperation agreement with Libero Thera of Japan

    Bai osaitu has a strategic cooperation agreement with Libero Thera of Japan

    • Last Update: 2021-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The two companies will conduct strategic cooperation in the development of all-human GPCR antibodies based on the antibody discovery platform of RenMab®, the world's most advanced all-human antibody mouse, and Libero Tera's outstanding antigen preparation technology, the company announced today.
    the collaboration aims to find therapeutic all-human GPCR antibodies.
    the agreement, the first phase of cooperation will jointly carry out anti-tumor antibody discovery for GPCR targets until the completion of the evaluation of drug llermic effectiveness in the body, to determine the lead antibody molecules.
    Libero Thera is responsible for antigen preparation and participation in in vitro antibody screening, and Baiosaitu will use its RenMab® mouse platform to conduct GPCR antibody discovery and complete the screening of lead antibody candidate molecules through drug ability evaluation techniques in animals.
    note: There are deletions in the original text
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.